BioPharma Dive 19. März 2026 AstraZeneca to boost cell therapy capabilities with new China investment
BioPharma Dive 18. März 2026 J&J wins FDA nod for psoriasis pill that aims to compete with top-selling injections
BioPharma Dive 18. März 2026 Chinese biotech startup Excalipoint banks $69M for next-gen T cell engagers
BioPharma Dive 16. März 2026 Sarepta tests new Elevidys safeguards; Sana advances diabetes cell therapy
BioPharma Dive 13. März 2026 With FDA go ahead, a China biotech notches a first in cell therapy testing
BioPharma Dive 13. März 2026 Evotec, Vistagen lay off staff; Immutep shares collapse on study failure